Skip to main content
NVAX logo

NVAX · Novavax Inc · Investor Relations

Track NVAX — free
$7.91 -0.06 (-0.69%) Play latest call Q2 2026 earnings call transcript
Market Cap
$1.31B
Shares
165.01M
Volume · Nov 19 1.15M Avg daily vol (3M) 6.86M

Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.

Recent news

Past events

Date Event Type
2026-11-17 Jefferies London Healthcare Conference Conference
2026-11-05 Novavax Inc Q3 FY2026 Earnings Call Earnings call
2026-11-05 Novavax Inc Q3 FY2026 Earnings Call Earnings call
2026-09-10 Citi’s 2026 BioPharma Back to School Conference Conference
2026-09-09 2026 Cantor Global Healthcare Conference Conference
2026-08-06 Novavax Inc Q2 FY2026 Earnings Call Earnings call
2026-06-04 Jefferies Global Healthcare Conference Conference
2026-05-13 Bank of America Securities 2026 Healthcare Conference Conference
2026-05-06 Novavax Inc Q1 FY2026 Earnings Call Earnings call
2026-03-11 Jefferies Biotech on the Beach Summit Event
2026-03-10 Leerink Partners 2026 Global Healthcare Conference Conference
2026-03-03 TD Cowen 46th Annual Health Care Conference Conference
2026-02-26 Novavax Inc Q4 FY2025 Earnings Call Earnings call
2026-01-14 Novavax to Participate in the 44th Annual J.P. Morgan Healthcare Conference Conference
2025-11-19 Jefferies London Healthcare Conference Conference
2025-11-06 Novavax to Report Third Quarter 2025 Financial Results on November 6, 2025 Event
2025-09-04 Novavax to Participate in the Cantor Global Healthcare Conference Conference
2025-08-06 Novavax to Report Second Quarter 2025 Financial Results on August 6, 2025 Event

Source: https://ir.novavax.com/

Key facts CIK 1000694 CUSIP 670002401 13F (30d) 290 filings 249 filers Visit website Investor relations